These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 31893563)

  • 21. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
    Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
    J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis.
    Rajda C; Galla Z; Polyák H; Maróti Z; Babarczy K; Pukoli D; Vécsei L
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Estimated Blood Volume and Body Mass Index on GFAP and NfL Levels in the Serum and CSF of Patients With Multiple Sclerosis.
    Yalachkov Y; Schäfer JH; Jakob J; Friedauer L; Steffen F; Bittner S; Foerch C; Schaller-Paule MA
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36316116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofilament light chain as an indicator of exacerbation prior to clinical symptoms in multiple sclerosis.
    Edwards KR; Garten L; Button J; O'Connor J; Kamath V; Frazier C
    Mult Scler Relat Disord; 2019 Jun; 31():59-61. PubMed ID: 30927733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease.
    Sánchez-Valle R; Heslegrave A; Foiani MS; Bosch B; Antonell A; Balasa M; Lladó A; Zetterberg H; Fox NC
    Alzheimers Res Ther; 2018 Nov; 10(1):113. PubMed ID: 30390718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High neurofilament levels are associated with clinically definite multiple sclerosis in children and adults with clinically isolated syndrome.
    van der Vuurst de Vries RM; Wong YYM; Mescheriakova JY; van Pelt ED; Runia TF; Jafari N; Siepman TA; Melief MJ; Wierenga-Wolf AF; van Luijn MM; Samijn JP; Neuteboom RF; Hintzen RQ
    Mult Scler; 2019 Jun; 25(7):958-967. PubMed ID: 29774770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS.
    Thebault S; R Tessier D; Lee H; Bowman M; Bar-Or A; Arnold DL; L Atkins H; Tabard-Cossa V; Freedman MS
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):e598. PubMed ID: 31516913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neurofilament light chain: a diagnostic potential for multiple sclerosis].
    Spirin NN; Kiseleva EV; Spirina NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(6):115-119. PubMed ID: 39072576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cerebrospinal Fluid in Multiple Sclerosis.
    Deisenhammer F; Zetterberg H; Fitzner B; Zettl UK
    Front Immunol; 2019; 10():726. PubMed ID: 31031747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
    Villar LM; Picón C; Costa-Frossard L; Alenda R; García-Caldentey J; Espiño M; Muriel A; Álvarez-Cermeño JC
    Eur J Neurol; 2015 Aug; 22(8):1169-75. PubMed ID: 25324032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.
    Lycke JN; Karlsson JE; Andersen O; Rosengren LE
    J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):402-4. PubMed ID: 9527161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
    Gaetani L; Salvadori N; Lisetti V; Eusebi P; Mancini A; Gentili L; Borrelli A; Portaccio E; Sarchielli P; Blennow K; Zetterberg H; Parnetti L; Calabresi P; Di Filippo M
    J Neurol; 2019 Sep; 266(9):2157-2163. PubMed ID: 31129709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
    Disanto G; Barro C; Benkert P; Naegelin Y; Schädelin S; Giardiello A; Zecca C; Blennow K; Zetterberg H; Leppert D; Kappos L; Gobbi C; Kuhle J;
    Ann Neurol; 2017 Jun; 81(6):857-870. PubMed ID: 28512753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.
    Ashton NJ; Leuzy A; Lim YM; Troakes C; Hortobágyi T; Höglund K; Aarsland D; Lovestone S; Schöll M; Blennow K; Zetterberg H; Hye A
    Acta Neuropathol Commun; 2019 Jan; 7(1):5. PubMed ID: 30626432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofilament light chain: A novel blood biomarker in patients with ataxia telangiectasia.
    Veenhuis SJG; Gupta AS; de Gusmão CM; Thornton J; Margus B; Rothblum-Oviatt C; Otto M; Halbgebauer S; van Os NJH; van de Warrenburg BPC; Verbeek MM; Willemsen MAAP
    Eur J Paediatr Neurol; 2021 May; 32():93-97. PubMed ID: 33878608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal function is associated with blood neurofilament light chain level in older adults.
    Akamine S; Marutani N; Kanayama D; Gotoh S; Maruyama R; Yanagida K; Sakagami Y; Mori K; Adachi H; Kozawa J; Maeda N; Otsuki M; Matsuoka T; Iwahashi H; Shimomura I; Ikeda M; Kudo T
    Sci Rep; 2020 Nov; 10(1):20350. PubMed ID: 33230211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Andreasson U; Zetterberg H; Blennow K;
    JAMA Neurol; 2017 May; 74(5):557-566. PubMed ID: 28346578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke.
    Pujol-Calderón F; Portelius E; Zetterberg H; Blennow K; Rosengren LE; Höglund K
    Neurosci Lett; 2019 Apr; 698():58-63. PubMed ID: 30599262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.